Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.
Don't know the stock symbol? Use the
Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier…
Sign up now to become a NASDAQ.com member and begin receiving instant notifications when key events occur that affect the stocks you follow.Access Now X
ETFs with ISIS as a Top 10 Holding*
|Weighting||ETF Name (Symbol)||100-Day Price Change (%)|
|0.91%||iShares Russell 2000 Growth ETF (IWO)||+11.91 (8.42%)|
|0.87%||Vanguard Russell 2000 Growth ETF (VTWG)||+8.92 (8.69%)|
|0.58%||Vanguard Small-Cap Growth ETF - DNQ (VBK)||+9.73 (7.74%)|
|0.47%||iShares Russell 2000 ETF (IWM)||+5.71 (4.80%)|
|0.47%||SPDR Russell 2000 ETF (TWOK)||+3.23 (4.56%)|
Company Description (as filed with the SEC)
We are the leading company in RNA-targeted drug discovery and development, exploiting a proven novel drug discovery platform we created to generate a broad pipeline of first-in-class or best-in-class antisense drugs. The efficiency and broad applicability of our drug discovery platform allows us to discover and develop antisense drugs to treat a wide range of diseases with an emphasis on cardiovascular, metabolic, severe and rare diseases, including neurological disorders, and cancer. The efficiency of our drug discovery technology allows us to employ a unique business strategy designed to maximize the value of our drugs and technology while maintaining an effective cost structure that limits our cash needs. Our business strategy is supported by our platform technology, our robust pipeline of drugs and our multifaceted partnering strategy, which have enabled us to focus on doing what we do best - to discover and develop novel antisense drugs. ... More ...
Where does ISIS fit in the risk graph?
|Annual EPS Est:||$-0.33|
|Quarterly EPS Est:||0.24|